Lakeshore Capital Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39M Sell
9,394
-34
-0.4% -$7.92K 1.77% 14
2026
Q1
$2.3M Buy
9,428
+169
+2% +$39.4K 1.88% 13
2025
Q4
$1.92M Buy
9,259
+251
+3% +$49.6K 1.53% 19
2025
Q3
$1.67M Buy
9,008
+265
+3% +$45.4K 1.35% 21
2025
Q2
$1.34M Buy
8,743
+1,475
+20% +$227K 1.18% 25
2025
Q1
$1.21M Buy
7,268
+362
+5% +$56.6K 1.16% 28
2024
Q4
$999K Buy
+6,906
New +$1.07M 1.51% 23

Other funds holding JNJ

Lakeshore Capital Group's JNJ Position: Q2 2026 in Review

Lakeshore Capital Group reduced its Johnson & Johnson (JNJ) stake by 0.36% in Q2 2026, selling an estimated $7.92K and leaving 9,394 shares worth $2.39M. The position accounts for 1.77% of the portfolio, ranked #14.

Lakeshore Capital Group first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Lakeshore Capital Group held 9,394 shares of Johnson & Johnson worth $2.39M as of Q2 2026.
  • Lakeshore Capital Group sold 34 Johnson & Johnson shares in Q2 2026, an estimated $7.92K.
  • Johnson & Johnson made up 1.77% of Lakeshore Capital Group's portfolio in Q2 2026, its #14 holding.
  • Lakeshore Capital Group first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Lakeshore Capital Group's 13F filing for Q2 2026, filed 31 Jul 2026.